Lv1
35 积分 2021-10-18 加入
Structure and dynamics of the CGRP receptor in apo and peptide-bound forms
1天前
待确认
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
9个月前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
9个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
9个月前
已完结
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
9个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
9个月前
已完结
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
9个月前
已完结
LBA0007 SAFETY AND EFFICACY OF DARATUMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS – A SINGLE-CENTER PHASE 2 OPEN-LABEL TRIAL
10个月前
已完结
Portfolio and project planning and management in the drug discovery, evaluation, development, and regulatory review process
10个月前
已完结
A PHASE 2 RANDOMIZED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF MYOSTATIN ANTIBODY LY2495655 VERSUS PLACEBO IN PATIENTS UNDERGOING ELECTIVE TOTAL HIP ARTHROPLASTY
11个月前
已关闭
皖公网安备34019202002308
